Progesterone for the Treatment of Traumatic Brain Injury (ProTECT III)

Wenle Zhao
The ProTECT study will determine if intravenous (IV) progesterone (started within 4 hours of injury and given for a total of 96 hours), is more effective than placebo for treating victims of moderate to severe acute traumatic brain injury.
This data center is not currently reporting usage information. For information on how your repository can submit usage information, please see our Documentation.